Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Erstellt von LADENBURG THALM/SH SH 

Marker Therapeutics Inc. diskutieren

Marker Therapeutics Inc.

WKN: A3D5YK / Symbol: MRKR / Name: Marker Therapeutics / Aktie / Small Cap /

1,13 €
-13,74 %

Einschätzung Buy
Rendite (%) -77,82 %
Kursziel 10,26
Veränderung
Endet am 30.04.25

Marker Therapeutics, Inc. (NASDAQ: MRKR) is now covered by analysts at LADENBURG THALM/SH SH. They set a "buy" rating and a $11.00 price target on the stock.
Ratings data for MRKR provided by MarketBeat

Einschätzung Buy
Rendite (%) -77,15 %
Kursziel 17,56
Veränderung
Endet am 21.10.25

Marker Therapeutics, Inc. (NASDAQ: MRKR) had its price target raised by analysts at LADENBURG THALM/SH SH from $11.00 to $19.00. They now have a "buy" rating on the stock.
Ratings data for MRKR provided by MarketBeat

Einschätzung Buy
Rendite (%) 13,00 %
Kursziel 11,55
Veränderung
Endet am 01.04.26

Marker Therapeutics, Inc. (NASDAQ: MRKR) had its "strong-buy" rating re-affirmed by analysts at WBB Securities. They now have a $12.50 price target on the stock.
Ratings data for MRKR provided by MarketBeat

Marker Therapeutics (NASDAQ:MRKR) was downgraded by analysts at Wall Street Zen from a "hold" rating to a "sell" rating.
Ratings data for MRKR provided by MarketBeat

Marker Therapeutics (NASDAQ:MRKR) is now covered by analysts at HC Wainwright. They set a "buy" rating on the stock.
Ratings data for MRKR provided by MarketBeat

Marker Therapeutics (NASDAQ:MRKR) had its "buy" rating reaffirmed by analysts at UBS Group AG.
Ratings data for MRKR provided by MarketBeat

Einschätzung Buy
Rendite (%) -13,74 %
Kursziel 8,59
Veränderung
Endet am 09.12.26

Marker Therapeutics (NASDAQ:MRKR) is now covered by analysts at HC Wainwright. They set a "buy" rating and a $10.00 price target on the stock.
Ratings data for MRKR provided by MarketBeat